| Kenneth Dalen, | |
|
44201 Dequindre Rd, Troy, MI 48085-1117 | |
| (248) 964-5190 | |
| Not Available |
| Full Name | Kenneth Dalen |
|---|---|
| Gender | Male |
| Speciality | Radiology - Diagnostic Radiology |
| Location | 44201 Dequindre Rd, Troy, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851350763 | NPI | - | NPPES |
| 2833757 | Medicaid | MI | |
| 300F362420 | Other | MI | BCBSM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 4301052664 (Michigan) | Primary |
| Entity Name | Troy Internal Medicine, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356450589 PECOS PAC ID: 0840282067 Enrollment ID: O20040330001398 |
News Archive
Tetraphase Pharmaceuticals Inc., a biopharmaceutical company capitalizing on breakthrough synthetic chemistry technology announced today that it will present three (3) posters and deliver a slide presentation on the synthesis and antibacterial activity of analogs from several novel classes of antibiotics to treat drug-resistant infections at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco, CA.
Curemark, LLC, a drug research and development company focused on the treatment of neurological diseases, announced that the U.S. Food and Drug Administration has given clearance to Curemark's Investigational New Drug application for a Phase III clinical trial for the use of CM – 4612 in the treatment of attention deficit hyperactivity disorder.
Coley Pharmaceutical Group has announced that Merck & Co has licensed Coley's VaxImmune vaccine adjuvant for incorporation into vaccines being developed by Merck for certain infectious diseases and Alzheimer's disease.
Protagen AG, a specialist for in-vitro diagnostics and GMP-compliant protein analysis, announced today that it received a Notice of Allowance by the Japanese Patent Office stating a favourable decision for the patent application 2000-547262 developed at the Max-Planck Institute for Molecular Genetics in Berlin, Germany. This patent claims broadly a method for identifying and selecting clones relating to the basic UNIclone® technology and is already granted in Europe with the publication number EP1073770 B1.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kenneth Dalen, 3601 W 13 Mile Rd, 400-fsc/pcs, Royal Oak, MI 48073-6712 Ph: () - | Kenneth Dalen, 44201 Dequindre Rd, Troy, MI 48085-1117 Ph: (248) 964-5190 |
News Archive
Tetraphase Pharmaceuticals Inc., a biopharmaceutical company capitalizing on breakthrough synthetic chemistry technology announced today that it will present three (3) posters and deliver a slide presentation on the synthesis and antibacterial activity of analogs from several novel classes of antibiotics to treat drug-resistant infections at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco, CA.
Curemark, LLC, a drug research and development company focused on the treatment of neurological diseases, announced that the U.S. Food and Drug Administration has given clearance to Curemark's Investigational New Drug application for a Phase III clinical trial for the use of CM – 4612 in the treatment of attention deficit hyperactivity disorder.
Coley Pharmaceutical Group has announced that Merck & Co has licensed Coley's VaxImmune vaccine adjuvant for incorporation into vaccines being developed by Merck for certain infectious diseases and Alzheimer's disease.
Protagen AG, a specialist for in-vitro diagnostics and GMP-compliant protein analysis, announced today that it received a Notice of Allowance by the Japanese Patent Office stating a favourable decision for the patent application 2000-547262 developed at the Max-Planck Institute for Molecular Genetics in Berlin, Germany. This patent claims broadly a method for identifying and selecting clones relating to the basic UNIclone® technology and is already granted in Europe with the publication number EP1073770 B1.
› Verified 3 days ago
Ming Lin Hsieh, Radiology Medicare: Accepting Medicare Assignments Practice Location: 44201 Dequindre Rd, Troy, MI 48085 Phone: 248-964-5190 | |
Marie Konczalski, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 44201 Dequindre Rd, Beaumont Hospital - Troy, Troy, MI 48085 Phone: 248-964-5190 Fax: 248-964-5199 | |
Brian Berger, Radiology Medicare: Accepting Medicare Assignments Practice Location: 44201 Dequindre Rd, Troy, MI 48085 Phone: 248-964-5190 | |
Tarun Gupta, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 44201 Dequindre Rd, Troy, MI 48085 Phone: 248-964-5000 | |
Robert Warren Mendelson, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 2541 Manchester Ct, Troy, MI 48098 Phone: 248-879-8100 Fax: 248-879-8300 | |
Dr. Krisha J Howell, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 4550 Investment Dr Ste B111, Troy, MI 48098 Phone: 248-952-5019 | |
Stephen Zintsmaster, Radiology Medicare: Accepting Medicare Assignments Practice Location: 44201 Dequindre Rd, Troy, MI 48085 Phone: 248-964-5190 Fax: 248-964-5199 |